286 related articles for article (PubMed ID: 23153812)
1. Recent advances in the development of selective human MAO-B inhibitors: (hetero)arylidene-(4-substituted-thiazol-2-yl)hydrazines.
Secci D; Bolasco A; Carradori S; D'Ascenzio M; Nescatelli R; Yáñez M
Eur J Med Chem; 2012 Dec; 58():405-17. PubMed ID: 23153812
[TBL] [Abstract][Full Text] [Related]
2. Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors.
Chimenti F; Bolasco A; Secci D; Chimenti P; Granese A; Carradori S; Yáñez M; Orallo F; Ortuso F; Alcaro S
Bioorg Med Chem; 2010 Aug; 18(15):5715-23. PubMed ID: 20615716
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and selective human monoamine oxidase B inhibition of heterocyclic hybrids based on hydrazine and thiazole scaffolds.
Carradori S; D'Ascenzio M; De Monte C; Secci D; Yáñez M
Arch Pharm (Weinheim); 2013 Jan; 346(1):17-22. PubMed ID: 23065686
[TBL] [Abstract][Full Text] [Related]
4. (Thiazol-2-yl)hydrazone derivatives from acetylpyridines as dual inhibitors of MAO and AChE: synthesis, biological evaluation and molecular modeling studies.
D'Ascenzio M; Chimenti P; Gidaro MC; De Monte C; De Vita D; Granese A; Scipione L; Di Santo R; Costa G; Alcaro S; Yáñez M; Carradori S
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):908-19. PubMed ID: 25807300
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives.
Chimenti F; Carradori S; Secci D; Bolasco A; Bizzarri B; Chimenti P; Granese A; Yáñez M; Orallo F
Eur J Med Chem; 2010 Feb; 45(2):800-4. PubMed ID: 19926363
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S
Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365
[TBL] [Abstract][Full Text] [Related]
7. Exploring 4-substituted-2-thiazolylhydrazones from 2-, 3-, and 4-acetylpyridine as selective and reversible hMAO-B inhibitors.
Chimenti P; Petzer A; Carradori S; D'Ascenzio M; Silvestri R; Alcaro S; Ortuso F; Petzer JP; Secci D
Eur J Med Chem; 2013 Aug; 66():221-7. PubMed ID: 23807114
[TBL] [Abstract][Full Text] [Related]
8. Chalcones: a valid scaffold for monoamine oxidases inhibitors.
Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S
J Med Chem; 2009 May; 52(9):2818-24. PubMed ID: 19378991
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, stereochemical separation, and biological evaluation of selective inhibitors of human MAO-B: 1-(4-arylthiazol-2-yl)-2-(3-methylcyclohexylidene)hydrazines.
Chimenti F; Secci D; Bolasco A; Chimenti P; Granese A; Carradori S; Yáñez M; Orallo F; Sanna ML; Gallinella B; Cirilli R
J Med Chem; 2010 Sep; 53(17):6516-20. PubMed ID: 20715818
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.
Matos MJ; Terán C; Pérez-Castillo Y; Uriarte E; Santana L; Viña D
J Med Chem; 2011 Oct; 54(20):7127-37. PubMed ID: 21923181
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
[TBL] [Abstract][Full Text] [Related]
12. Identification of the stereochemical requirements in the 4-aryl-2-cycloalkylidenhydrazinylthiazole scaffold for the design of selective human monoamine oxidase B inhibitors.
D'Ascenzio M; Carradori S; Secci D; Mannina L; Sobolev AP; De Monte C; Cirilli R; Yáñez M; Alcaro S; Ortuso F
Bioorg Med Chem; 2014 May; 22(10):2887-95. PubMed ID: 24746464
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel N-substituted imidazolecarboxylic acid hydrazides as monoamine oxidase inhibitors.
Hadizadeh F; Ghodsi R
Farmaco; 2005 Mar; 60(3):237-40. PubMed ID: 15784243
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins.
Chimenti F; Secci D; Bolasco A; Chimenti P; Bizzarri B; Granese A; Carradori S; Yáñez M; Orallo F; Ortuso F; Alcaro S
J Med Chem; 2009 Apr; 52(7):1935-42. PubMed ID: 19267475
[TBL] [Abstract][Full Text] [Related]
15. Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies.
Jagrat M; Behera J; Yabanoglu S; Ercan A; Ucar G; Sinha BN; Sankaran V; Basu A; Jayaprakash V
Bioorg Med Chem Lett; 2011 Jul; 21(14):4296-300. PubMed ID: 21680183
[TBL] [Abstract][Full Text] [Related]
16. Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors.
Pisani L; Catto M; Nicolotti O; Grossi G; Di Braccio M; Soto-Otero R; Mendez-Alvarez E; Stefanachi A; Gadaleta D; Carotti A
Eur J Med Chem; 2013; 70():723-39. PubMed ID: 24231308
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological assessment of new thiazolylhydrazine derivatives as selective and reversible hMAO-A inhibitors.
Can NÖ; Osmaniye D; Levent S; Sağlık BN; Korkut B; Atlı Ö; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2018 Jan; 144():68-81. PubMed ID: 29248751
[TBL] [Abstract][Full Text] [Related]
18. Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives.
Vishnu Nayak B; Ciftci-Yabanoglu S; Jadav SS; Jagrat M; Sinha BN; Ucar G; Jayaprakash V
Eur J Med Chem; 2013 Nov; 69():762-7. PubMed ID: 24099995
[TBL] [Abstract][Full Text] [Related]
19. 4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis.
Secci D; Carradori S; Petzer A; Guglielmi P; D'Ascenzio M; Chimenti P; Bagetta D; Alcaro S; Zengin G; Petzer JP; Ortuso F
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):597-612. PubMed ID: 30727777
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
